Brigitte de Lima, PhD CFA
Senior Director, Corporate Development at AstraZeneca
Brigitte de Lima, PhD CFA
Brigitte de Lima is a highly experienced finance professional currently serving as the Senior Director of Corporate Development at AstraZeneca, a leading global biopharmaceutical company.1 With nearly 20 years of expertise in the pharmaceutical, biotech, and life sciences sectors, she has held various leadership roles at prominent firms such as goetzpartners, Bryan, Garnier & Co, and Merrill Lynch.1
Key Highlights
- Senior Director, Corporate Development at AstraZeneca (January 2020 - Present)1
- Chartered Financial Analyst (CFA) Charterholder1
- PhD in Virology/Molecular Biology from the University of Cambridge1
- Fluent in German, Spanish, Portuguese, and English1
- Previously worked as an Equity Analyst covering biotech, midcap pharma, and diagnostics stocks1
Education and Certifications
- PhD, Virology/Molecular Biology, University of Cambridge (2001-2004)1
- CFA Charterholder, CFA Institute (2006-2009)1
- Licenciatura, Bioquímica, University of Lisbon (1995-2000)1
Brigitte's diverse background, combining scientific research and financial expertise, has made her a valuable asset in the pharmaceutical and biotech industries. Her extensive experience in corporate development, equity research, and M&A advisory positions her as a respected leader in her field.
People also Viewed
Mutual Connections
People also Viewed
Mutual Connections
Brigitte de Lima, PhD CFA
Senior Director, Corporate Development at AstraZeneca
Brigitte de Lima, PhD CFA
Brigitte de Lima is a highly experienced finance professional currently serving as the Senior Director of Corporate Development at AstraZeneca, a leading global biopharmaceutical company.1 With nearly 20 years of expertise in the pharmaceutical, biotech, and life sciences sectors, she has held various leadership roles at prominent firms such as goetzpartners, Bryan, Garnier & Co, and Merrill Lynch.1
Key Highlights
- Senior Director, Corporate Development at AstraZeneca (January 2020 - Present)1
- Chartered Financial Analyst (CFA) Charterholder1
- PhD in Virology/Molecular Biology from the University of Cambridge1
- Fluent in German, Spanish, Portuguese, and English1
- Previously worked as an Equity Analyst covering biotech, midcap pharma, and diagnostics stocks1
Education and Certifications
- PhD, Virology/Molecular Biology, University of Cambridge (2001-2004)1
- CFA Charterholder, CFA Institute (2006-2009)1
- Licenciatura, Bioquímica, University of Lisbon (1995-2000)1
Brigitte's diverse background, combining scientific research and financial expertise, has made her a valuable asset in the pharmaceutical and biotech industries. Her extensive experience in corporate development, equity research, and M&A advisory positions her as a respected leader in her field.
People also Viewed